TFF PHARMACEUTICALS, INC. (TFFP): Price and Financial Metrics


Today's Latest Price: $17.02 USD

0.80 (-4.49%)

Updated Jan 25 4:00pm

Add TFFP to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 484 in Biotech

See all "A" rated Strong Buy stocks

TFFP Stock Price Chart Interactive Chart >

Price chart for TFFP

TFFP Price/Volume Stats

Current price $17.02 52-week high $21.14
Prev. close $17.82 52-week low $3.44
Day low $16.51 Volume 270,800
Day high $18.01 Avg. volume 388,987
50-day MA $15.87 Dividend yield N/A
200-day MA $11.30 Market Cap 378.29M


TFF Pharmaceuticals, Inc. operates as an early-stage biopharmaceutical company. The Company develops powder and molecule drugs for the treatment of chronic respiratory diseases and lung conditions. TFF Pharmaceuticals serves clients in the State of Texas.

TFFP Latest News Stream

Event/Time News Detail
Loading, please wait...

TFFP Latest Social Stream

Loading social stream, please wait...

View Full TFFP Social Stream

Latest TFFP News From Around the Web

Below are the latest news stories about TFF Pharmaceuticals Inc that investors may wish to consider to help them evaluate TFFP as an investment opportunity.

TFF Pharmaceuticals Announces First Dosing of Asthma Patients with Voriconazole Inhalation Powder in a Phase 1b Clinical Trial

AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals announces first dosing of asthma patients with Voriconazole Inhalation Powder in a Ph.1b clinical trial for the treatment of IPA.

Business Wire | December 15, 2020

TFF Pharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference

AUSTIN, Texas--(BUSINESS WIRE)-- #Jefferies--TFF Pharmaceuticals to present at the Jefferies Virtual London Healthcare Conference, with a corporate presentation on November 19, at 2:55 PM ET.

Business Wire | November 12, 2020

We're Not Very Worried About TFF Pharmaceuticals' (NASDAQ:TFFP) Cash Burn Rate

We can readily understand why investors are attracted to unprofitable companies. Indeed, TFF Pharmaceuticals...

Yahoo | November 8, 2020

TFF Pharmaceuticals Reports Third Quarter 2020 Financial and Business Results

AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals reports third quarter 2020 financial and business results - Conference call today, Thursday, November 5, 2020 at 4:30pm ET

Business Wire | November 5, 2020

TFF Pharmaceuticals and Felix Biotechnology Sign Letter of Intent for a Collaboration, Development and License Agreement

AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals and Felix Biotechnology sign Letter of Intent for a Collaboration, Development and License Agreement for bacteriophage therapies.

Business Wire | November 5, 2020

Read More 'TFFP' Stories Here

TFFP Price Returns

1-mo N/A
3-mo 27.30%
6-mo 88.27%
1-year 239.04%
3-year N/A
5-year N/A
YTD 18.85%
2020 167.66%
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9533 seconds.